Literature DB >> 17035940

Catch-up growth follows an abnormal pattern in experimental renal insufficiency and growth hormone treatment normalizes it.

I Molinos1, F Santos, E Carbajo-Perez, E Garcia, J Rodriguez, O Garcia-Alvarez, H Gil, F A Ordoñez, V Loredo, L Mallada.   

Abstract

The primary goal of this study was to determine if the ability to undergo catch-up growth following a transient injury is preserved in an experimental model of moderate chronic renal failure (CRF) and the effect of growth hormone (GH) administration on such phenomenon. Young rats were subtotally nephrectomized (days 0 and 4) (Nx). From days 11 to 13, food intake was restricted in subgroups of Nx and control (C) rats (NxR and CR). After refeeding, subgroups of NxR and CR rats received GH from days 14 to 20 (NxRGH and CRGH). Rats were killed on days 14 (C, CR, Nx, NxR), 17 and 21 (C, CR, CRGH, Nx, NxR, NxRGH), and 36 (C, CR, Nx, NxR). Longitudinal growth rate was measured by osseous front advance in the proximal tibiae. With refeeding, growth rate of CR, NxR, and NXrGH rats became significantly greater than that of C, indicating catch-up growth. This occurred later and with lower growth rate in NxR than in CR rats, whereas the characteristics of catch-up growth in CR and NxRGH animals were similar. Changes in growth rate were associated with modifications in the morphology and proliferative activity of growth cartilage. We conclude that catch-up growth occurs in renal insufficiency but follows a different pattern from that observed with normal renal function. GH treatment normalizes the pattern of catch-up growth in CRF. Changes in growth velocity are associated to modifications in the structure and dynamics of growth cartilage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035940     DOI: 10.1038/sj.ki.5001949

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up.

Authors:  Alberto Roselló-Díez; Alexandra L Joyner
Journal:  Endocr Rev       Date:  2015-10-20       Impact factor: 19.871

Review 2.  Bone Disease in CKD in Children.

Authors:  Fernando Santos; Lucas Díaz-Anadón; Flor A Ordóñez; Dieter Haffner
Journal:  Calcif Tissue Int       Date:  2021-01-16       Impact factor: 4.333

3.  Effects of growth hormone treatment on growth plate, bone, and mineral metabolism of young rats with uremia induced by adenine.

Authors:  Débora Claramunt; Helena Gil-Peña; Rocío Fuente; Enrique García-López; Olaya Hernández Frías; Flor A Ordoñez; Julián Rodríguez-Suárez; Fernando Santos
Journal:  Pediatr Res       Date:  2017-04-26       Impact factor: 3.756

4.  Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease.

Authors:  Oleh Akchurin; Angara Sureshbabu; Steve B Doty; Yuan-Shan Zhu; Edwin Patino; Susanna Cunningham-Rundles; Mary E Choi; Adele Boskey; Stefano Rivella
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20

Review 5.  Growth-plate cartilage in chronic renal failure.

Authors:  Cheryl P Sanchez
Journal:  Pediatr Nephrol       Date:  2009-10-09       Impact factor: 3.714

6.  Growth hormone improves growth retardation induced by rapamycin without blocking its antiproliferative and antiangiogenic effects on rat growth plate.

Authors:  Óscar Álvarez-García; Enrique García-López; Vanessa Loredo; Helena Gil-Peña; Natalia Mejía-Gaviria; Julián Rodríguez-Suárez; Flor Á Ordóñez; Fernando Santos
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.